Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.49 and traded as low as $0.48. Elite Pharmaceuticals shares last traded at $0.48, with a volume of 407,701 shares trading hands.
Elite Pharmaceuticals Stock Performance
The stock has a market capitalization of $488.78 million, a PE ratio of -22.88 and a beta of 0.14. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.90 and a current ratio of 3.27. The firm has a 50 day moving average of $0.49 and a 200-day moving average of $0.49.
Elite Pharmaceuticals (OTCMKTS:ELTP – Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The specialty pharmaceutical company reported ($0.01) EPS for the quarter. Elite Pharmaceuticals had a negative return on equity of 6.92% and a negative net margin of 25.70%.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Featured Articles
- Five stocks we like better than Elite Pharmaceuticals
- How Can Investors Benefit From After-Hours Trading
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How to Buy Cheap Stocks Step by Step
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
